XML 14 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Cash flows from operating activities          
Net income $ 6,408 $ 7,860 $ 15,096 $ 12,236 $ 97,700
Adjustments to reconcile net income to net cash used in operating activities:          
Depreciation and amortization     600 454  
Debt prepayment penalty and amortization of debt issuance costs     73 1,380  
Impairment of property, equipment, and inventory     0 517  
Stock-based compensation expense     1,173 1,543  
Earnings from equity method investments (10,155) (13,754) (23,969) (19,331)  
Gain on sale of equity method investment 0 0 0 (2,078)  
Gain on settlement of note payable and licensed technology     0 (1,019)  
Other non-cash items, net     436 34  
Changes in operating assets and liabilities:          
Receivables     6,690 (627)  
Related party receivables     68 1,473  
Prepaid expenses and other assets     (453) 806  
Costs incurred on uncompleted contracts     25,634 17,201  
Deferred tax asset, net     8,106 0  
Other long-term assets     (767) (2,630)  
Accounts payable     (303) (2,910)  
Accrued payroll and related liabilities     (987) (1,596)  
Other current liabilities     (1,227) (101)  
Billings on uncompleted contracts     (28,671) (20,910)  
Other long-term liabilities     164 (1,954)  
Legal settlements and accruals     (10,685) 2,767  
Distributions from equity method investees, return on investment     2,875 5,900  
Net cash used in operating activities     (6,147) (8,845)  
Cash flows from investing activities          
Distributions from equity method investees in excess of cumulative earnings     22,313 14,875  
Maturity of investment securities, restricted     0 336  
Acquisition of property and equipment, net     (247) (111)  
Contributions to equity method investees     0 (223)  
Proceeds from sale of equity method investment     0 1,773  
Net cash provided by investing activities     22,066 16,650  
Cash flows from financing activities          
Borrowings on Line of Credit     808 0  
Repayments on Line of Credit     (808) 0  
Repayments on notes payable, related party     0 (14,496)  
Short-term borrowing loan costs and debt prepayment penalty     0 (807)  
Repurchase of common shares to satisfy tax withholdings     (517) (85)  
Repurchase of common shares     (12,973) 0  
Net cash used in financing activities     (13,490) (15,388)  
Increase (decrease) in Cash and Cash Equivalents and Restricted Cash     2,429 (7,583)  
Cash and Cash Equivalents and Restricted Cash, beginning of period     26,944 20,973 20,973
Cash and Cash Equivalents and Restricted Cash, end of period 29,373 $ 13,390 29,373 13,390 26,944
Supplemental disclosure of cash flow information:          
Cash paid for interest     1,791 1,436  
Cash paid (refunded) for income taxes     839 (72)  
Supplemental disclosure of non-cash investing and financing activities:          
Stock award reclassification (liability to equity)     0 899  
Settlement of RCM6 note payable     0 13,234  
Non-cash reduction of equity method investment     0 $ 11,156  
Dividends payable $ 5,268   $ 5,268   $ 0